Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: CCA, FVT

UpHealth to Announce Financial Results for the Third Quarter 2021 on November 10, 2021

DELRAY BEACH, Fla., Oct. 28, 2021 /PRNewswire/ -- UpHealth, Inc. (NYSE: UPH) ("UpHealth" or the "Company"), a global digital health company delivering technology platforms, infrastructure, and services to modernize care delivery and health management, today announced that it will release financial results for its third quarter ended September 30, 2021, after market close on Wednesday, November 10, 2021. 

A press release and supplemental materials, including a management webcast discussion, will be issued after the stock market closes. UpHealth management will then host a live question-and-answer session with investors and analysts beginning at 5:00 p.m. Eastern Daylight Time. The webcast will be archived for approximately 30 days and made available on the Investor Relations section of the Company's web site at https://investors.uphealthinc.com/events-and-presentations/default.aspx.

About UpHealth Inc.
UpHealth is a global digital health company that delivers digital-first technology, infrastructure and services to dramatically improve how healthcare is delivered and managed. The UpHealth platform creates digitally enabled "care communities" that can improve access, outcomes, and costs with digital health solutions and interoperability tools that serve patients wherever they are, in their native language. UpHealth's clients include global governments, health plans, healthcare providers and community-based organizations.

For more information, please visit https://uphealthinc.com and follow us at @UpHealthInc on Twitter and UpHealth Inc. on LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of U.S. federal securities laws. Such forward-looking statements include, but are not limited to, statements regarding product offerings of UpHealth, and reception of its product by customers. Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to projections, forecasts, or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intends," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. The forward-looking statements contained in this press release are based on certain assumptions and analyses made by the management of UpHealth in light of their respective experience and perception of historical trends, current conditions, and expected future developments and their potential effects on UpHealth as well as other factors they believe are appropriate in the circumstances. There can be no assurance that future developments affecting UpHealth will be those anticipated. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond the control of the parties), or other assumptions that may cause actual results or performance to be materially different from those expressed or implied by these forward-looking statements, including the mix of services utilized by UpHealth's customers and such customers' needs for these services, market acceptance of new service offerings, the ability of UpHealth to expand what it does for existing customers as well as to add new customers, that UpHealth will have sufficient capital to operate as anticipated, and the impact that the novel coronavirus and the illness, COVID-19, that it causes, as well as government responses to deal with the spread of this illness and the reopening of economies that have been closed as part of these responses, may have on UpHealth's operations, the demand for UpHealth's products, global supply chains and economic activity in general. Should one or more of these risks or uncertainties materialize or should any of the assumptions being made prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as may be required under applicable securities laws.

SOURCE UpHealth, Inc.

These press releases may also interest you

at 07:55
The "Anesthesia Video Laryngoscope Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global anesthesia video laryngoscope market exhibited...

at 07:50
The global construction market is set for a sustained period of strong growth post-Covid-19, driven by government spending on infrastructure and the transition to a net zero society. However, the switch to more sustainable buildings and...

at 07:50
The "Lymphoma Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global lymphoma treatment market grew at a CAGR of around 8% during...

at 07:45
The "Pharmerging Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global pharmerging market exhibited strong growth during 2015-2020. Looking...

at 07:45
Jazz Pharmaceuticals plc along with partner PharmaMar (MSE: PHM) have announced the commercial availability of ZepzelcaTM (lurbinectedin) after receiving conditional approval by Health Canada in September 2021. Zepzelca is the first new treatment in...

at 07:45
In July, four million Americans quit their jobs. In August & September, an aggregate of more than another eight million quit. A...

News published on 28 october 2021 at 09:00 and distributed by: